The price-to-earnings ratio for China SXT Pharmaceuticals Inc (NASDAQ: SXTC) is above average at 0.75x, Company’s 36-month beta value is 1.26. The public float for
The price-to-earnings ratio for China SXT Pharmaceuticals Inc (NASDAQ: SXTC) is above average at 0.64x. The 36-month beta value for SXTC is also noteworthy at
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has seen a rise in its stock price by 44.94 in relation to its previous close of 1.58. However,
The stock of China SXT Pharmaceuticals Inc (SXTC) has seen a -18.80% decrease in the past week, with a -19.14% drop in the past month,
China SXT Pharmaceuticals Inc (NASDAQ: SXTC)’s stock price has dropped by -32.00 in relation to previous closing price of 2.50. Nevertheless, the company has seen
© 2024, Powered by Smart TechOne
